MedStar Health, a leader in oncology research and comprehensive cancer care with ten hospitals in Washington, D.C. and Maryland, is the first entire system in the Caris Precision Oncology Alliance™.
As a Network member, MedStar Health will actively participate in the development of standards of care and best practices for integrating and utilizing molecular profiling in oncology practice, while also striving to increase widespread adoption and patient access to personalized medicine in clinical settings. MedStar Health will also leverage Caris’ multiple-technology tumor profiling service, Caris Molecular Intelligence®, to enable the practice of precision medicine by identifying therapy options and clinical trial opportunities based on the unique characteristics of a patient’s tumor.
This collaboration amplifies the work begun in January of 2015, when John L. Marshall, M.D., became Chairman of the Network. Dr. Marshall is professor of medicine and oncology at Georgetown University School of Medicine, and chief of hematology/oncology at Georgetown Lombardi Comprehensive Cancer Center/MedStar Georgetown University Hospital.
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and MedStar Georgetown University Hospital, was established in 1970, and is a state-of-the-art cancer center housing more than 240,000 square feet of clinic and research space. The director of the Cancer Center is Louis M. Weiner, MD.
In 1974, Georgetown Lombardi became the 16th National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the country. Today, we remain the only center with this designation in the Washington, DC, area, and one of just 41 in the nation, and working closely with Caris Life Sciences, are at the vanguard of profiling tumors genetically and proteomically, as a key component of advancing care for the many thousands of patients we see each year.